新锐医药(06108)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06108 新锐医药

未开盘 08-21 13:10:03

0.225

+0.016

+7.66%

最高0.225	最低0.221	成交量7.20万
今开0.224	昨收0.209	日振幅1.91%
总市值4,522万	流通市值4,522万	总股本2.01亿
成交额1.61万	换手率0.04%	流通股本2.01亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06108","market":"HK","secType":"STK","nameCN":"新锐医药","latestPrice":0.225,"timestamp":1787289003418,"preClose":0.209,"halted":0,"volume":72000,"delay":0,"changeRate":0.07655502392344504,"floatShares":200999999,"shares":200999999,"eps":-0.1194,"marketStatus":"未开盘","change":0.016,"latestTime":"08-21 13:10:03","open":0.224,"high":0.225,"low":0.221,"amount":16064,"amplitude":0.019139,"askPrice":0.225,"askSize":8000,"bidPrice":0.209,"bidSize":56000,"shortable":0,"etf":0,"ttmEps":-0.1,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787535000000},"marketStatusCode":0,"adr":0,"listingDate":1382630400000,"exchange":"SEHK","adjPreClose":0.209,"openAndCloseTimeList":[[1787275800000,1787284800000],[1787288400000,1787299200000]],"volumeRatio":11.421319978130077,"lotSize":8000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06108","defaultTab":"news","newsList":[{"id":"1194711974","title":"新锐医药（06108）定于8月27日审议2026年中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1194711974","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1194711974?lang=zh_cn&edition=full","pubTime":"2026-08-14 20:41","pubTimestamp":1786711260,"startTime":"0","endTime":"0","summary":"新锐医药（06108）14日公告称，董事会将于2026年8月27日（星期四）召开会议，届时将审议并批准公司及其附属公司截至2026年6月30日止六个月的未经审计中期业绩及有关公告，并讨论是否派付股息（如有）。\\n\\n公告显示，会议决议如获通过，将涉及披露公司2026年中期经营及财务表现，并决定潜在股息派付安排。该公告由董事会主席、行政总裁兼执行董事王秋勤于2026年8月14日在香港签署。\\n\\n截至公告日，公司执行董事包括王秋勤、褚雪平及周湾；独立非执行董事为梁志坚、李倩明及施礼贤。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06108"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197178712","title":"新锐医药（06108）调整百慕达注册及股份过户登记总处地址","url":"https://stock-news.laohu8.com/highlight/detail?id=1197178712","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1197178712?lang=zh_cn&edition=full","pubTime":"2026-08-03 20:35","pubTimestamp":1785760545,"startTime":"0","endTime":"0","summary":"新锐医药（06108）8月3日晚间公告称，自2026年8月3日起，公司在百慕达的注册办事处及股份过户登记总处将由现址迁至“Richmond House, 12 Par-la-Ville Road, Hamilton HM 08, Bermuda”。\\n\\n公司在香港的股份过户登记分处维持不变，继续由卓佳证券登记有限公司负责，地址为香港夏悫道16号远东金融中心17楼。\\n\\n公告显示，变更地址事宜由公司董事会发布，现任主席兼执行董事为王秋勤。公司董事会成员包括执行董事王秋勤女士、褚雪平先生、周湾女士，以及独立非执行董事梁志坚先生、李倩明女士、施礼贤先生。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06108"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192326230","title":"新锐医药更新2026年7月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1192326230","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1192326230?lang=zh_cn&edition=full","pubTime":"2026-08-03 18:27","pubTimestamp":1785752834,"startTime":"0","endTime":"0","summary":"新锐医药国际控股有限公司于2026年8月3日公布截至2026年7月31日止的证券变动月报表。该报告显示，公司截至报告期末的法定注册股本为15,000,000,000股，面值每股0.01港元，对应总额150,000,000港元。本期法定注册股本与上月一致。本期公司已发行普通股数量为200,616,665股，较上月无增减变动，库存股数量亦保持为0股。本月未发生任何新增发行、回购、注销或库存股份变动。公司表示，将继续严格遵守香港联交所《上市规则》及相关法律法规。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06108"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164033788","title":"新锐医药6月股份变动月报：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1164033788","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164033788?lang=zh_cn&edition=full","pubTime":"2026-07-02 17:56","pubTimestamp":1782986217,"startTime":"0","endTime":"0","summary":"新锐医药国际控股有限公司于2026年7月2日披露了截至2026年6月30日的证券变动月报表。根据公告，公司本月未进行任何新增发行或股份购回，也不存在股份注销或库藏股变动。公告并确认，所有证券发行及股份变动均经董事会批准，符合香港联交所《上市规则》等相关法规的要求。公司表示将持续遵守香港联交所的各项规定，保持信息披露的透明与合规。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06108"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159224816","title":"新锐医药2026年5月股份变动月报：股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1159224816","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1159224816?lang=zh_cn&edition=full","pubTime":"2026-06-02 16:42","pubTimestamp":1780389749,"startTime":"0","endTime":"0","summary":"新锐医药国际控股有限公司于2026年6月2日发布截至2026年5月31日的月度股份变动报告。报告显示，该公司本月授权及已发行股本均未发生变化，股本结构持续保持稳定。截至2026年5月31日，已发行股份总数为200,616,665股，与上月持平，未出现新增发行、购回或注销股票的情况，亦未有库藏股变动。公司确认已遵守香港联合交易所有限公司的相关上市规则及适用的法律规定。公告由公司秘书吴日升签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06108"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180506252","title":"新锐医药更新2026年4月股份变动月报表，股本保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1180506252","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1180506252?lang=zh_cn&edition=full","pubTime":"2026-05-04 17:17","pubTimestamp":1777886256,"startTime":"0","endTime":"0","summary":"新锐医药于2026年5月4日发布截至2026年4月30日的证券变动月报表。公告显示，公司法定股本总数仍为15,000,000,000股普通股，每股面值为0.01港元，总金额为150,000,000港元，与上月保持一致。已发行股份总数为200,616,665股，无库藏股，公司确认符合主要上市规则有关公众持股量的要求。公司现有一项于2013年10月25日采纳的购股权计划，期末持有购股权数量为12,820,000份，与上月相同，报告期内未有新股发行或购回记录。本次公告由公司秘书吴日升签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06108"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145154150","title":"新锐医药授予董事股份购回授权，规模达已发行股本一成","url":"https://stock-news.laohu8.com/highlight/detail?id=1145154150","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1145154150?lang=zh_cn&edition=full","pubTime":"2026-04-27 20:46","pubTimestamp":1777294000,"startTime":"0","endTime":"0","summary":"新锐医药国际控股有限公司董事会宣布，已向股东提呈普通决议案，以授予董事一般及无条件授权，在股东周年大会通过后，可于香港联交所或其他获准交易所购回公司不超过当日已发行股份总数的10%。本公司提醒股东需留意投票及股份过户登记的具体安排。董事会建议股东审慎行使表决权。根据公告，若该授权顺利获得通过，董事会将在适当情况下行使回购权，以实现为股东创造更大回报的目标。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"新锐医药授予董事股份购回授权，规模达已发行股本一成","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06108"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101827026","title":"新锐医药(06108)2025年收入同比增长约38.9%，核心分销业务稳步扩张","url":"https://stock-news.laohu8.com/highlight/detail?id=1101827026","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1101827026?lang=zh_cn&edition=full","pubTime":"2026-04-27 20:46","pubTimestamp":1777293990,"startTime":"0","endTime":"0","summary":"新锐医药于2025年度在主营业务方面取得收入约130.37百万港元，相比2024年的93.95百万港元增长约38.9%，带动整体经营规模进一步扩大。医疗及相关产品分销及贸易板块为主要收入来源，推出新产品并在内地市场实施分级分类管理策略，推动该分部收入由88.7百万港元增至127.9百万港元。另一个提供销售及推广服务的板块因部分推广产品挂网下跌或终止销售，全年收入减少超过半数。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"新锐医药(06108)2025年收入同比增长约38.9%，核心分销业务稳步扩张","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06108"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187368898","title":"新锐医药3月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1187368898","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1187368898?lang=zh_cn&edition=full","pubTime":"2026-04-02 17:11","pubTimestamp":1775121082,"startTime":"0","endTime":"0","summary":"新锐医药国际控股有限公司于2026年4月2日发布截至2026年3月31日的月报表。报告显示，公司本月并未出现任何新增股份发行、回购或注销活动，整体股本结构维持不变。报告期内，公司法定股本维持15,000,000,000股，面值为每股0.01港元，合计法定股本总额为150,000,000港元；已发行股份总数为200,616,665股，与上月保持一致，同时未出现库存股。公司声称将继续遵守香港联交所《上市规则》及其他相关法律法规的要求。公告由公司秘书吴日升签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06108"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622077601","title":"新锐医药(06108)发布年度业绩 净亏损约为2010万港元 同比减少约35.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622077601","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2622077601?lang=zh_cn&edition=full","pubTime":"2026-03-25 22:57","pubTimestamp":1774450660,"startTime":"0","endTime":"0","summary":"智通财经APP讯，新锐医药(06108)发布截至2025年12月31日止年度全年业绩，收益约1.3亿港元，同比增加约38.9%。公司拥有人应占净亏损约为2010万港元，同比减少约35.2%。每股亏损11.94港仙。公告称，净亏损减少主要由于并无2024财政年度录得的于接近到期日的滞销存货导致存货减值亏损约1310万港元;推广成本减少约210万港元;营销服务费减少约370万港元;及分销权预付款项摊销减少约210万港元(2024财政年度：约350万港元)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419107.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06108","BK1511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135594707","title":"新锐医药2025年收入增至1.304亿元港元，净亏损同比收窄逾三成","url":"https://stock-news.laohu8.com/highlight/detail?id=1135594707","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1135594707?lang=zh_cn&edition=full","pubTime":"2026-03-25 22:49","pubTimestamp":1774450171,"startTime":"0","endTime":"0","summary":"新锐医药公布截至二零二五年十二月三十一日止年度业绩。相应毛利约0.161亿元港元，同比上升约40%。尽管收入与毛利均有提升，集团全年仍录得净亏损约0.201亿元港元，较上一年度收窄约35.2%。董事会建议不派付本年度之末期股息。提供营销及推广服务的收入约0.024亿元港元，较上一年度减少约53.8%，该分部收入主要来自医药产品推广及市场营销等相关服务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06108"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199361077","title":"新锐医药（6108）2月股份维持不变，股本保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1199361077","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1199361077?lang=zh_cn&edition=full","pubTime":"2026-03-02 16:52","pubTimestamp":1772441552,"startTime":"0","endTime":"0","summary":"2026年3月2日，新锐医药国际控股有限公司发布2026年2月月报表。报告期为2026年2月1日至2026年2月28日，公司公告显示：。已发行股份数量为200,616,665股，无新增发行、回购或注销情况，库存股份数量也保持为零。公司于2013年10月25日采纳的购股权计划仍有12,820,000份购股权在册，当月并未有行使或终止，因此未导致已发行股份增减。截至2月底，公司已发行股份总数和股本结构保持稳定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06108"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613219879","title":"新锐医药盘中异动 临近收盘大幅跳水6.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613219879","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2613219879?lang=zh_cn&edition=full","pubTime":"2026-02-20 15:55","pubTimestamp":1771574133,"startTime":"0","endTime":"0","summary":"2026年02月20日临近收盘15时55分，新锐医药股票出现异动，股价大幅下跌6.67%。截至发稿，该股报0.224港元/股，成交量8.8万股，换手率0.04%，振幅6.67%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。新锐医药股票所在的药品分销行业中，整体跌幅为1.88%。其相关个股中，叮当健康、TE HEALTHCARE、满贯集团涨幅较大，振幅较大的相关个股有京东健康、百信国际、思派健康，振幅分别为7.01%、6.67%、6.44%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022015553497a68dd0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022015553497a68dd0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06108","BK1511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514120352","title":"所有产品任职回报均为负，大成基金“新锐医药投资黑马”引质疑","url":"https://stock-news.laohu8.com/highlight/detail?id=2514120352","media":"媒体滚动","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514120352?lang=zh_cn&edition=full","pubTime":"2025-02-28 07:02","pubTimestamp":1740697320,"startTime":"0","endTime":"0","summary":"　　春节后A股持续回暖，但大成基金旗下基金经理邹建管理的多只产品却“逆市亏损”。　　《华夏时报》记者在大成基金官网看到，邹建管理的所有产品的任职回报均为负数。　　针对产品业绩等问题，《华夏时报》记者2月24日联系大成基金客服人员并发送采访函。　　大成基金的官网中有一张基金经理邹建的海报，上面写着“新锐医药投资黑马”的字样。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-02-28/doc-inemysvx0255281.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06108","BK1511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512047146","title":"新锐医药盘中异动 早盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512047146","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512047146?lang=zh_cn&edition=full","pubTime":"2025-02-19 10:43","pubTimestamp":1739933037,"startTime":"0","endTime":"0","summary":"2025年02月19日早盘10时43分，新锐医药股票出现异动，股价大幅上涨5.00%。截至发稿，该股报0.042港元/股，成交量28万股，换手率0.02%，振幅2.50%。新锐医药股票所在的药品分销行业中，整体跌幅为0.37%。其相关个股中，CLSA PREMIUM、新锐医药、阿里健康涨幅较大，振幅较大的相关个股有CLSA PREMIUM、叮当健康、阿里健康，振幅分别为48.65%、11.67%、9.29%。新锐医药公司简介：新锐医药国际控股有限公司是一家主要从事医药产品分销及贸易业务的公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219104357abd44fd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219104357abd44fd5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06108","BK1511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512905770","title":"新锐医药盘中异动 快速下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512905770","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512905770?lang=zh_cn&edition=full","pubTime":"2025-02-18 09:39","pubTimestamp":1739842770,"startTime":"0","endTime":"0","summary":"2025年02月18日早盘09时39分，新锐医药股票出现波动，股价大幅下跌5.00%。截至发稿，该股报0.038港元/股，成交量148万股，换手率0.09%，振幅2.50%。资金方面，该股资金流入7296港元，流出5.0136万港元。新锐医药股票所在的药品分销行业中，整体涨幅为0.17%。新锐医药公司简介：新锐医药国际控股有限公司是一家主要从事医药产品分销及贸易业务的公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218093930a249db92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218093930a249db92&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06108","BK1511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509513157","title":"新锐医药(06108)股价上升10%，现价港币$0.044","url":"https://stock-news.laohu8.com/highlight/detail?id=2509513157","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509513157?lang=zh_cn&edition=full","pubTime":"2025-02-07 11:00","pubTimestamp":1738897200,"startTime":"0","endTime":"0","summary":"[上升股]新锐医药(06108) 股价在上午11:00比前收市价上升10%，现股价为港币$0.044。至目前为止，今日最高价为$0.044，而最低价为$0.041。总成交量为109.6万股，总成交金额为港币$4.654万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152547499_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152547499_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2502071800/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2502071800/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["06108","BK1511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509730431","title":"新锐医药盘中异动 股价大涨7.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509730431","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509730431?lang=zh_cn&edition=full","pubTime":"2025-02-07 09:30","pubTimestamp":1738891837,"startTime":"0","endTime":"0","summary":"2025年02月07日早盘09时30分，新锐医药股票出现异动，股价急速拉升7.50%。截至发稿，该股报0.043港元/股，成交量33.6万股，换手率0.02%，振幅2.50%。新锐医药股票所在的药品分销行业中，整体跌幅为0.10%。其相关个股中，新锐医药、方舟健客、CLSA PREMIUM涨幅较大，振幅较大的相关个股有新锐医药、京东健康、阿里健康，振幅分别为2.50%、1.23%、1.06%。新锐医药公司简介：新锐医药国际控股有限公司是一家主要从事医药产品分销及贸易业务的公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207093037a23c5bec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207093037a23c5bec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1511","06108"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509888424","title":"新锐医药盘中异动 下午盘大幅跳水6.67%报0.042港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509888424","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509888424?lang=zh_cn&edition=full","pubTime":"2025-02-05 14:21","pubTimestamp":1738736502,"startTime":"0","endTime":"0","summary":"2025年02月05日下午盘14时21分，新锐医药股票出现异动，股价急速下跌6.67%。截至发稿，该股报0.042港元/股，成交量29.6万股，换手率0.02%，振幅6.67%。资金方面，该股资金流入7768港元，流出5040港元。新锐医药股票所在的药品分销行业中，整体跌幅为0.22%。其相关个股中，大健康国际、百信国际、澳至尊涨幅较大，振幅较大的相关个股有大健康国际、方舟健客、CLSA PREMIUM，振幅分别为16.00%、7.84%、6.72%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205142142a239efee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205142142a239efee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06108","BK1511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508948372","title":"新锐医药盘中异动 股价大涨7.14%报0.045港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508948372","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508948372?lang=zh_cn&edition=full","pubTime":"2025-02-04 13:36","pubTimestamp":1738647415,"startTime":"0","endTime":"0","summary":"2025年02月04日下午盘13时36分，新锐医药股票出现异动，股价急速上涨7.14%。截至发稿，该股报0.045港元/股，成交量286.4万股，换手率0.17%，振幅9.52%。资金方面，该股资金流入9.6824万港元，流出2.2312万港元。新锐医药股票所在的药品分销行业中，整体涨幅为0.16%。其相关个股中，方舟健客、阿里健康、京东健康-R涨幅较大，振幅较大的相关个股有方舟健客、大健康国际、百信国际，振幅分别为12.93%、11.90%、7.41%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020413365596177aff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020413365596177aff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06108","BK1511"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.newraymedicine.com","stockEarnings":[{"period":"1week","weight":0.0181},{"period":"1month","weight":0.0181},{"period":"3month","weight":0.0976},{"period":"6month","weight":0.0045},{"period":"1year","weight":-0.4578},{"period":"ytd","weight":-0.1818}],"compareEarnings":[{"period":"1week","weight":0.0355},{"period":"1month","weight":0.0449},{"period":"3month","weight":0.0158},{"period":"6month","weight":-0.0153},{"period":"1year","weight":0.036},{"period":"ytd","weight":0.0148}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"新锐医药国际控股有限公司是一家主要从事医药分销贸易以及提供营销和推广服务的投资控股公司。该公司通过两个分部开展业务。医药及相关产品分销及贸易分部主要从事药品及医药化学试剂分销及贸易。提供营销及推广服务分部主要从事提供药品及医药化学试剂的营销及推广服务。该公司主要在中国国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.131615},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.053553},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.062306},{"month":4,"riseRate":0.571429,"avgChangeRate":1.15111},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.127188},{"month":6,"riseRate":0.142857,"avgChangeRate":-0.078607},{"month":7,"riseRate":0,"avgChangeRate":-0.203423},{"month":8,"riseRate":0.25,"avgChangeRate":0.993164},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.050416},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.050818},{"month":11,"riseRate":0.166667,"avgChangeRate":-0.079375},{"month":12,"riseRate":0.5,"avgChangeRate":-0.006947}],"exchange":"SEHK","name":"新锐医药","nameEN":"NEW RAY MEDIC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"新锐医药(06108)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供新锐医药(06108)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"新锐医药,06108,新锐医药股票,新锐医药股票老虎,新锐医药股票老虎国际,新锐医药行情,新锐医药股票行情,新锐医药股价,新锐医药股市,新锐医药股票价格,新锐医药股票交易,新锐医药股票购买,新锐医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"新锐医药(06108)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供新锐医药(06108)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}